Africa stands at a pivotal moment in its journey toward health security and self-reliance. Scientific capacity is expanding and biomanufacturing is scaling up—yet global health financing is declining, putting hard-won progress at risk and exposing fragile systems. This moment calls for African-led solutions more than ever.
ACHIEVE Africa is an African-led, African Union member-state-championed continental response to this moment—a US$100+ million initiative designed to close Africa’s research and development gap, and strengthen the continent’s engine for vaccines and biologics, from discovery through clinical trials and regulatory readiness.
Rooted in the African Union’s Agenda 2063 and aligned with the goal of producing 60% of Africa’s vaccines locally by 2040, ACHIEVE Africa builds the full value chain from discovery to delivery—designing, developing, testing, and manufacturing vaccines and biologics end to end, for health priorities defined by Africa.
African scientists from 20 countries and 50 institutions are engaged so far. Governments, organizations, and philanthropies are welcome to contribute to scientific strengthening, technology transfer, human resource development, funding matching, and collaboration.
ACHIEVE Africa was launched through a co-convening by:
